Kezar Life Sciences Inc (NAS:KZR)
$ 0.7699 0.0042 (0.55%) Market Cap: 56.05 Mil Enterprise Value: -105.77 Mil PE Ratio: 0 PB Ratio: 0.33 GF Score: 28/100

Kezar Life Sciences Inc At TMA's International Annual Patient Conference Transcript

Sep 22, 2020 / NTS GMT
Release Date Price: $4.88 (-2.01%)
Unidentified Participant

Thanks you so much for joining this session. Again, I'm [Chai Hong], I'm one of the Board of Directors for TMA, and I will introduce the speakers, who will play out a video and then we'll open up to live Q&A at the end.

So it is my pleasure to introduce our next presenters, Dr. Noreen Roth Henig, Chief Medical Officer; and Dr. Mary Katherine (MK) Farmer, Senior Medical Director of Kezar Life Sciences, Inc. Kezar Life Sciences is a South San Francisco-based biotechnology company that combines courage, conviction, and cutting-edge science to develop breakthrough treatments for immune mediated and oncologic disorders, helping patients to overcome their disease and live a better life.

Dr. Henig is an accomplished leader whose career spans clinical practice, academic medicine, translational science, clinical development, medical and regulatory affairs. She is a Board-certified physician in pulmonary critical care and Board eligible in allergy and immunology. Dr. Henig received her BA from (

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot